Using bioinformation approaches, we discovered HIBCH and MGME1 as novel biomarkers to identify the underlying processes of mitochondrial dynamics that cause impaired mitochondrial function in Alzheimer's disease, and HIBCH was linked to Tau metabolism. The gene discussed is MAPT; the disease is Alzheimer disease.